Type 1 Diabetes Information Center
Per-person diabetes-attributable costs ranged from 374 in New Mexico to 1,610 in Washington, D.C.
A survey of individuals with type 1 diabetes mellitus consuming a very low-carbohydrate diet indicated that many study participants were able to maintain glycemic control within national ideal glycemic target ranges.
Artificial pancreas treatments are safe and effective for managing type 1 diabetes.
The CDC conducted a study to estimate the prevalence of diagnosed diabetes among adults in 2016 by primary type.
Oral insulin usage does not prevent the development of type 1 diabetes in relatives of patients.
Insulin pump therapy is linked to lower risks of severe hypoglycemia and diabetic ketoacidosis and better glycemic control than insulin injection therapy.
However, long-term type 1 diabetes is associated with hand pain, disability, and stiffness.
A 36-year-old man with type 1 diabetes presents to the emergency room with hyperglycemia and possible diabetic ketoacidosis after not taking his insulin for 3 days.
The FDA approves an "artifical pancreas" for patients over 14 years of age.
Pediatric patients with type 1 diabetes often have low levels of vitamin D.